By Michael Susin Destiny Pharma said Wednesday that it has appointed Chris Tovey as chief executive officer with effect from Sept. 1. The London-listed.
Destiny Pharma PLC - Brighton, England-based clinical-stage biotechnology company focused on preventing life-threatening infections - Appoints Chris Tovey as chief executive officer from September 1,.
Destiny Pharma plc (LON:DEST – Free Report) reached a new 52-week low on Thursday . The company traded as low as GBX 27 ($0.34) and last traded at GBX 27.60 ($0.35), with a volume of 280033 shares. The stock had previously closed at GBX 29.40 ($0.37). Analysts Set New Price Targets Separately, Shore Capital reaffirmed […]
Destiny Pharma plc (LON:DEST – Get Rating) was down 0.3% during mid-day trading on Friday . The company traded as low as GBX 30 ($0.38) and last traded at GBX 30.50 ($0.38). Approximately 97,684 shares traded hands during mid-day trading, a decline of 73% from the average daily volume of 367,528 shares. The stock had […]
Destiny Pharma PLC (AIM:DEST, OTC:DTTYF) chief executive Neil Clark is stepping down as boss to pursue new challenges. Dr Debra Barker, a non-executive.